- Acquired by N2OFF, Mar 2025
About
MitoCareX Bio is a drug discovery company focusing on the discovery and development of novel therapies for hard-to-treat lung cancer by targeting mitochondrial transporters (SLC25 protein family).
To discover new potential drugs targeting human mitochondrial carriers, MitoCareX Bio has developed its MITOLINE algorithm and other advanced computational capabilities to generate reliable 3D models for its mitochondrial proteins of interest – a major key step for utilizing CADD. To recognize novel small molecule scaffolds interacting with their proteins of interest, it uses its advanced cloud-based computational platform to efficiently screen numerous small molecules against our 3D models. The selected hit candidates are then progressed along the pre-clinical path.
Q&A
- What is MitoCareX Bio's primary focus?
- MitoCareX Bio is a drug discovery company focused on developing novel therapies for hard-to-treat lung cancer by targeting mitochondrial transporters (SLC25 protein family).
- When was MitoCareX Bio founded?
- MitoCareX Bio was founded in February 2022.
- What is the current status of MitoCareX Bio?
- MitoCareX Bio was acquired by N2OFF in March 2025.
- What technology does MitoCareX Bio utilize for drug discovery?
- MitoCareX Bio developed its MITOLINE algorithm and advanced computational capabilities to generate reliable 3D models for mitochondrial proteins of interest, which are then used with a cloud-based computational platform to screen small molecules.
- How many employees does MitoCareX Bio have?
- MitoCareX Bio has 1-10 employees.
- Who is the founder of MitoCareX Bio?
- Alon Silberman is the Founder & CSO of MitoCareX Bio.
- Where is MitoCareX Bio headquartered?
- MitoCareX Bio is headquartered in Tel Aviv-Yafo, Israel.
Team · 1
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | mitocarexbio.com/ |
|---|---|
| linkedin.com/company/81288396/ |
Identifiers & details
| Founded | 2022-2 |
|---|---|
| Employees (exact) | 5 |
| Status reason | Acquired by N2OFF on Mar, 2025 |
Acquisitions & public offerings
Acquired by N2OFF 2025-03
Radar intelligence
Web history (Wayback)
| Domain | mitocarexbio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|